longtext: 1VA5-pdb

content
HEADER    TRANSFERASE                             11-FEB-04   1VA5
TITLE     ANTIGEN 85C WITH OCTYLTHIOGLUCOSIDE IN ACTIVE SITE
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: ANTIGEN 85-C;
COMPND   3 CHAIN: A, B;
COMPND   4 EC: 2.3.1.-;
COMPND   5 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS;
SOURCE   3 ORGANISM_COMMON: BACTERIA;
SOURCE   4 GENE: FBPC2;
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   6 EXPRESSION_SYSTEM_COMMON: BACTERIA;
SOURCE   7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3);
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE   9 EXPRESSION_SYSTEM_PLASMID: PET29
KEYWDS    ALPHA-BETA HYDROLASE
EXPDTA    X-RAY DIFFRACTION
AUTHOR    D.R.RONNING,V.VISSA,G.S.BESRA,J.T.BELISLE,J.C.SACCHETTINI
REVDAT   2   07-SEP-04 1VA5    1       JRNL
REVDAT   1   06-JUL-04 1VA5    0
JRNL        AUTH   D.R.RONNING,V.VISSA,G.S.BESRA,J.T.BELISLE,
JRNL        AUTH 2 J.C.SACCHETTINI
JRNL        TITL   MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85A AND 85C
JRNL        TITL 2 STRUCTURES CONFIRM BINDING ORIENTATION AND
JRNL        TITL 3 CONSERVED SUBSTRATE SPECIFICITY
JRNL        REF    J.BIOL.CHEM.                  V. 279 36771 2004
JRNL        REFN   ASTM JBCHA3  US ISSN 0021-9258
REMARK   1
REMARK   2
REMARK   2 RESOLUTION. 2.02 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : CNS 1.1
REMARK   3   AUTHORS     : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK   3               : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,
REMARK   3               : READ,RICE,SIMONSON,WARREN
REMARK   3
REMARK   3  REFINEMENT TARGET : ENGH & HUBER
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 38.72
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : 507000.610
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : 0.0000
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : 94.6
REMARK   3   NUMBER OF REFLECTIONS             : 43409
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE            (WORKING SET) : 0.187
REMARK   3   FREE R VALUE                     : 0.211
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.000
REMARK   3   FREE R VALUE TEST SET COUNT      : 2172
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : 0.005
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 6
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 2.02
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 2.15
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 91.00
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : 6561
REMARK   3   BIN R VALUE           (WORKING SET) : 0.1830
REMARK   3   BIN FREE R VALUE                    : 0.2180
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : 4.60
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : 318
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : 0.012
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 4406
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 80
REMARK   3   SOLVENT ATOMS            : 252
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 9.40
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 17.30
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : 2.75000
REMARK   3    B22 (A**2) : -3.91000
REMARK   3    B33 (A**2) : 1.16000
REMARK   3    B12 (A**2) : 0.00000
REMARK   3    B13 (A**2) : -0.74000
REMARK   3    B23 (A**2) : 0.00000
REMARK   3
REMARK   3  ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM LUZZATI PLOT        (A) : 0.19
REMARK   3   ESD FROM SIGMAA              (A) : 0.04
REMARK   3   LOW RESOLUTION CUTOFF        (A) : 5.00
REMARK   3
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : 0.22
REMARK   3   ESD FROM C-V SIGMAA          (A) : 0.10
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.
REMARK   3   BOND LENGTHS                 (A) : 0.006
REMARK   3   BOND ANGLES            (DEGREES) : 1.30
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : 22.90
REMARK   3   IMPROPER ANGLES        (DEGREES) : 0.92
REMARK   3
REMARK   3  ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA
REMARK   3   MAIN-CHAIN BOND              (A**2) : 1.140 ; 1.500
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : 1.680 ; 2.000
REMARK   3   SIDE-CHAIN BOND              (A**2) : 1.770 ; 2.000
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : 2.510 ; 2.500
REMARK   3
REMARK   3  BULK SOLVENT MODELING.
REMARK   3   METHOD USED : FLAT MODEL
REMARK   3   KSOL        : 0.38
REMARK   3   BSOL        : 49.99
REMARK   3
REMARK   3  NCS MODEL : NULL
REMARK   3
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL
REMARK   3
REMARK   3  PARAMETER FILE  1  : PROTEIN_REP.PARAM
REMARK   3  PARAMETER FILE  2  : WATER.PARAM
REMARK   3  PARAMETER FILE  3  : THIO.PARAM
REMARK   3  PARAMETER FILE  4  : NULL
REMARK   3  TOPOLOGY FILE  1   : PROTEIN.TOP
REMARK   3  TOPOLOGY FILE  2   : WATER.TOP
REMARK   3  TOPOLOGY FILE  3   : THIO.TOP
REMARK   3  TOPOLOGY FILE  4   : NULL
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: NULL
REMARK   4
REMARK   4 1VA5 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-FEB-2004.
REMARK 100 THE RCSB ID CODE IS RCSB006398.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 04-AUG-2000
REMARK 200  TEMPERATURE           (KELVIN) : 100.0
REMARK 200  PH                             : 6.50
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : N
REMARK 200  RADIATION SOURCE               : ROTATING ANODE
REMARK 200  BEAMLINE                       : NULL
REMARK 200  X-RAY GENERATOR MODEL          : RIGAKU RU200
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.5418
REMARK 200  MONOCHROMATOR                  : NI MIRROR + NI FILTER
REMARK 200  OPTICS                         : MIRRORS
REMARK 200
REMARK 200  DETECTOR TYPE                  : IMAGE PLATE
REMARK 200  DETECTOR MANUFACTURER          : MACSCIENCE
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 44080
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.020
REMARK 200  RESOLUTION RANGE LOW       (A) : 38.720
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 95.2
REMARK 200  DATA REDUNDANCY                : 3.000
REMARK 200  R MERGE                    (I) : NULL
REMARK 200  R SYM                      (I) : 0.04200
REMARK 200   FOR THE DATA SET  : 17.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.12
REMARK 200  COMPLETENESS FOR SHELL     (%) : 83.9
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL
REMARK 200  R MERGE FOR SHELL          (I) : NULL
REMARK 200  R SYM FOR SHELL            (I) : 0.11400
REMARK 200   FOR SHELL         : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: PDB ENTRY 1DZQ
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 53.39
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: OCTYLTHIOGLUCOSIDE, SODIUM ACETATE,
REMARK 280  IMIDAZOLE, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE
REMARK 280  293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X,Y,-Z
REMARK 290       3555   1/2+X,1/2+Y,Z
REMARK 290       4555   1/2-X,1/2+Y,-Z
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       72.40900
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       34.05850
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       72.40900
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       34.05850
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT
REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR
REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S).
REMARK 350
REMARK 350 GENERATING THE BIOMOLECULE
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 350 BIOMOLECULE: 2
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350   BIOMT1   2  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   2  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   2  0.000000  0.000000  1.000000        0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     ALA A   283
REMARK 465     THR A   284
REMARK 465     PRO A   285
REMARK 465     PRO A   286
REMARK 465     ALA A   287
REMARK 465     ALA A   288
REMARK 465     PRO A   289
REMARK 465     ALA A   290
REMARK 465     ALA A   291
REMARK 465     PRO A   292
REMARK 465     ALA A   293
REMARK 465     ALA A   294
REMARK 465     LEU A   295
REMARK 465     GLY A   296
REMARK 465     HIS A   297
REMARK 465     HIS A   298
REMARK 465     HIS A   299
REMARK 465     HIS A   300
REMARK 465     HIS A   301
REMARK 465     HIS A   302
REMARK 465     ALA B   283
REMARK 465     THR B   284
REMARK 465     PRO B   285
REMARK 465     PRO B   286
REMARK 465     ALA B   287
REMARK 465     ALA B   288
REMARK 465     PRO B   289
REMARK 465     ALA B   290
REMARK 465     ALA B   291
REMARK 465     PRO B   292
REMARK 465     ALA B   293
REMARK 465     ALA B   294
REMARK 465     LEU B   295
REMARK 465     GLY B   296
REMARK 465     HIS B   297
REMARK 465     HIS B   298
REMARK 465     HIS B   299
REMARK 465     HIS B   300
REMARK 465     HIS B   301
REMARK 465     HIS B   302
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991
REMARK 500
REMARK 500  M RES CSSEQI ATM1   RES CSSEQI ATM2   DEVIATION
REMARK 500    ARG A   3   CA    ARG A   3   C      0.043
REMARK 500    MET A 192   SD    MET A 192   CE     0.040
REMARK 500    PRO B   4   CG    PRO B   4   CD     0.035
REMARK 500    PRO B  54   CB    PRO B  54   CG     0.041
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991
REMARK 500
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3
REMARK 500    ARG A   3   N   -  CA  -  C   ANGL. DEV. = 12.2 DEGREES
REMARK 500    PRO A   4   N   -  CA  -  C   ANGL. DEV. = 13.2 DEGREES
REMARK 500    PRO A   4   C   -  N   -  CA  ANGL. DEV. =  8.9 DEGREES
REMARK 500    GLY A   5   N   -  CA  -  C   ANGL. DEV. =-16.3 DEGREES
REMARK 500    ASN A  52   N   -  CA  -  C   ANGL. DEV. =  8.7 DEGREES
REMARK 500    PHE A 150   N   -  CA  -  C   ANGL. DEV. = -8.9 DEGREES
REMARK 500    LEU A 151   N   -  CA  -  C   ANGL. DEV. = 11.0 DEGREES
REMARK 500    ARG A 204   N   -  CA  -  C   ANGL. DEV. = -8.5 DEGREES
REMARK 500    SER A 215   N   -  CA  -  C   ANGL. DEV. = -7.8 DEGREES
REMARK 500    VAL A 251   N   -  CA  -  C   ANGL. DEV. = -8.1 DEGREES
REMARK 500    TRP A 262   N   -  CA  -  C   ANGL. DEV. =  8.4 DEGREES
REMARK 500    ASN B  52   N   -  CA  -  C   ANGL. DEV. =  7.9 DEGREES
REMARK 500    PHE B 150   N   -  CA  -  C   ANGL. DEV. =-10.1 DEGREES
REMARK 500    LEU B 151   N   -  CA  -  C   ANGL. DEV. = 11.1 DEGREES
REMARK 500    SER B 215   N   -  CA  -  C   ANGL. DEV. = -7.8 DEGREES
REMARK 500    TRP B 262   N   -  CA  -  C   ANGL. DEV. =  8.4 DEGREES
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    SER B   2      -76.02    105.86
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1DQY   RELATED DB: PDB
REMARK 900 SAME PROTEIN WITH COVALENT INHIBITOR
REMARK 900 RELATED ID: 1DQZ   RELATED DB: PDB
REMARK 900 SAME PROTEIN WITH NOTHING BOUND
REMARK 900 RELATED ID: 1F0N   RELATED DB: PDB
REMARK 900 HOMOLOGOUS PROTEIN
REMARK 900 RELATED ID: 1F0P   RELATED DB: PDB
REMARK 900 HOMOLOGOUS PROTEIN WITH TREHALOSE BOUND
DBREF  1VA5 A    1   294  SWS    P31953   A85C_MYCTU      47    340
DBREF  1VA5 B    1   294  SWS    P31953   A85C_MYCTU      47    340
SEQADV 1VA5 MET A    0  SWS  P31953              INITIATING METHIONINE
SEQADV 1VA5 LEU A  295  SWS  P31953              HIS TAG
SEQADV 1VA5 GLY A  296  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS A  297  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS A  298  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS A  299  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS A  300  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS A  301  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS A  302  SWS  P31953              HIS TAG
SEQADV 1VA5 MET B    0  SWS  P31953              INITIATING METHIONINE
SEQADV 1VA5 LEU B  295  SWS  P31953              HIS TAG
SEQADV 1VA5 GLY B  296  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS B  297  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS B  298  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS B  299  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS B  300  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS B  301  SWS  P31953              HIS TAG
SEQADV 1VA5 HIS B  302  SWS  P31953              HIS TAG
SEQRES   1 A  303  MET PHE SER ARG PRO GLY LEU PRO VAL GLU TYR LEU GLN
SEQRES   2 A  303  VAL PRO SER ALA SER MET GLY ARG ASP ILE LYS VAL GLN
SEQRES   3 A  303  PHE GLN GLY GLY GLY PRO HIS ALA VAL TYR LEU LEU ASP
SEQRES   4 A  303  GLY LEU ARG ALA GLN ASP ASP TYR ASN GLY TRP ASP ILE
SEQRES   5 A  303  ASN THR PRO ALA PHE GLU GLU TYR TYR GLN SER GLY LEU
SEQRES   6 A  303  SER VAL ILE MET PRO VAL GLY GLY GLN SER SER PHE TYR
SEQRES   7 A  303  THR ASP TRP TYR GLN PRO SER GLN SER ASN GLY GLN ASN
SEQRES   8 A  303  TYR THR TYR LYS TRP GLU THR PHE LEU THR ARG GLU MET
SEQRES   9 A  303  PRO ALA TRP LEU GLN ALA ASN LYS GLY VAL SER PRO THR
SEQRES  10 A  303  GLY ASN ALA ALA VAL GLY LEU SER MET SER GLY GLY SER
SEQRES  11 A  303  ALA LEU ILE LEU ALA ALA TYR TYR PRO GLN GLN PHE PRO
SEQRES  12 A  303  TYR ALA ALA SER LEU SER GLY PHE LEU ASN PRO SER GLU
SEQRES  13 A  303  GLY TRP TRP PRO THR LEU ILE GLY LEU ALA MET ASN ASP
SEQRES  14 A  303  SER GLY GLY TYR ASN ALA ASN SER MET TRP GLY PRO SER
SEQRES  15 A  303  SER ASP PRO ALA TRP LYS ARG ASN ASP PRO MET VAL GLN
SEQRES  16 A  303  ILE PRO ARG LEU VAL ALA ASN ASN THR ARG ILE TRP VAL
SEQRES  17 A  303  TYR CYS GLY ASN GLY THR PRO SER ASP LEU GLY GLY ASP
SEQRES  18 A  303  ASN ILE PRO ALA LYS PHE LEU GLU GLY LEU THR LEU ARG
SEQRES  19 A  303  THR ASN GLN THR PHE ARG ASP THR TYR ALA ALA ASP GLY
SEQRES  20 A  303  GLY ARG ASN GLY VAL PHE ASN PHE PRO PRO ASN GLY THR
SEQRES  21 A  303  HIS SER TRP PRO TYR TRP ASN GLU GLN LEU VAL ALA MET
SEQRES  22 A  303  LYS ALA ASP ILE GLN HIS VAL LEU ASN GLY ALA THR PRO
SEQRES  23 A  303  PRO ALA ALA PRO ALA ALA PRO ALA ALA LEU GLY HIS HIS
SEQRES  24 A  303  HIS HIS HIS HIS
SEQRES   1 B  303  MET PHE SER ARG PRO GLY LEU PRO VAL GLU TYR LEU GLN
SEQRES   2 B  303  VAL PRO SER ALA SER MET GLY ARG ASP ILE LYS VAL GLN
SEQRES   3 B  303  PHE GLN GLY GLY GLY PRO HIS ALA VAL TYR LEU LEU ASP
SEQRES   4 B  303  GLY LEU ARG ALA GLN ASP ASP TYR ASN GLY TRP ASP ILE
SEQRES   5 B  303  ASN THR PRO ALA PHE GLU GLU TYR TYR GLN SER GLY LEU
SEQRES   6 B  303  SER VAL ILE MET PRO VAL GLY GLY GLN SER SER PHE TYR
SEQRES   7 B  303  THR ASP TRP TYR GLN PRO SER GLN SER ASN GLY GLN ASN
SEQRES   8 B  303  TYR THR TYR LYS TRP GLU THR PHE LEU THR ARG GLU MET
SEQRES   9 B  303  PRO ALA TRP LEU GLN ALA ASN LYS GLY VAL SER PRO THR
SEQRES  10 B  303  GLY ASN ALA ALA VAL GLY LEU SER MET SER GLY GLY SER
SEQRES  11 B  303  ALA LEU ILE LEU ALA ALA TYR TYR PRO GLN GLN PHE PRO
SEQRES  12 B  303  TYR ALA ALA SER LEU SER GLY PHE LEU ASN PRO SER GLU
SEQRES  13 B  303  GLY TRP TRP PRO THR LEU ILE GLY LEU ALA MET ASN ASP
SEQRES  14 B  303  SER GLY GLY TYR ASN ALA ASN SER MET TRP GLY PRO SER
SEQRES  15 B  303  SER ASP PRO ALA TRP LYS ARG ASN ASP PRO MET VAL GLN
SEQRES  16 B  303  ILE PRO ARG LEU VAL ALA ASN ASN THR ARG ILE TRP VAL
SEQRES  17 B  303  TYR CYS GLY ASN GLY THR PRO SER ASP LEU GLY GLY ASP
SEQRES  18 B  303  ASN ILE PRO ALA LYS PHE LEU GLU GLY LEU THR LEU ARG
SEQRES  19 B  303  THR ASN GLN THR PHE ARG ASP THR TYR ALA ALA ASP GLY
SEQRES  20 B  303  GLY ARG ASN GLY VAL PHE ASN PHE PRO PRO ASN GLY THR
SEQRES  21 B  303  HIS SER TRP PRO TYR TRP ASN GLU GLN LEU VAL ALA MET
SEQRES  22 B  303  LYS ALA ASP ILE GLN HIS VAL LEU ASN GLY ALA THR PRO
SEQRES  23 B  303  PRO ALA ALA PRO ALA ALA PRO ALA ALA LEU GLY HIS HIS
SEQRES  24 B  303  HIS HIS HIS HIS
HET    SOG   1001      20
HET    SOG   1002      20
HET    SOG   1003      20
HET    SOG   1004      20
HETNAM     SOG 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,
HETNAM   2 SOG  5-TRIOL
HETSYN     SOG 1-S-OCTYL-BETA-D-THIOGLUCOSIDE
FORMUL   3  SOG    4(C14 H28 O5 S1)
FORMUL   7  HOH   *252(H2 O1)
HELIX    1   1 ASN A   47  THR A   53  1                                   7
HELIX    2   2 PRO A   54  TYR A   60  1                                   7
HELIX    3   3 LYS A   94  ARG A  101  1                                   8
HELIX    4   4 ARG A  101  GLY A  112  1                                  12
HELIX    5   5 SER A  124  TYR A  137  1                                  14
HELIX    6   6 TRP A  157  SER A  169  1                                  13
HELIX    7   7 ASN A  173  GLY A  179  1                                   7
HELIX    8   8 ASP A  183  ASN A  189  1                                   7
HELIX    9   9 GLN A  194  ASN A  202  1                                   9
HELIX   10  10 ASN A  221  ASP A  245  1                                  25
HELIX   11  11 SER A  261  GLY A  282  1                                  22
HELIX   12  12 ASN B   47  THR B   53  1                                   7
HELIX   13  13 PRO B   54  TYR B   60  1                                   7
HELIX   14  14 LYS B   94  ARG B  101  1                                   8
HELIX   15  15 ARG B  101  GLY B  112  1                                  12
HELIX   16  16 SER B  124  TYR B  137  1                                  14
HELIX   17  17 TRP B  157  SER B  169  1                                  13
HELIX   18  18 ASN B  173  GLY B  179  1                                   7
HELIX   19  19 PRO B  184  ASN B  189  1                                   6
HELIX   20  20 GLN B  194  ASN B  201  1                                   8
HELIX   21  21 ASN B  221  ASP B  245  1                                  25
HELIX   22  22 SER B  261  GLY B  282  1                                  22
SHEET    1   A 8 VAL A   8  SER A  15  0
SHEET    2   A 8 ARG A  20  GLN A  27 -1  O  PHE A  26   N  GLU A   9
SHEET    3   A 8 SER A  65  PRO A  69 -1  O  MET A  68   N  GLN A  25
SHEET    4   A 8 ALA A  33  LEU A  36  1  N  LEU A  36   O  ILE A  67
SHEET    5   A 8 ALA A 119  LEU A 123  1  O  ALA A 119   N  TYR A  35
SHEET    6   A 8 TYR A 143  LEU A 147  1  O  ALA A 145   N  ALA A 120
SHEET    7   A 8 ARG A 204  TYR A 208  1  O  TYR A 208   N  SER A 146
SHEET    8   A 8 GLY A 250  ASN A 253  1  O  VAL A 251   N  VAL A 207
SHEET    1   B 8 VAL B   8  SER B  15  0
SHEET    2   B 8 ARG B  20  GLN B  27 -1  O  PHE B  26   N  GLU B   9
SHEET    3   B 8 SER B  65  PRO B  69 -1  O  MET B  68   N  GLN B  25
SHEET    4   B 8 ALA B  33  LEU B  36  1  N  LEU B  36   O  ILE B  67
SHEET    5   B 8 ALA B 119  LEU B 123  1  O  ALA B 119   N  TYR B  35
SHEET    6   B 8 TYR B 143  LEU B 147  1  O  ALA B 145   N  ALA B 120
SHEET    7   B 8 ARG B 204  TYR B 208  1  O  TYR B 208   N  SER B 146
SHEET    8   B 8 GLY B 250  ASN B 253  1  O  VAL B 251   N  VAL B 207
CRYST1  144.818   68.117   82.281  90.00 119.60  90.00 C 1 2 1       8
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.006905  0.000000  0.003923        0.00000
SCALE2      0.000000  0.014681  0.000000        0.00000
SCALE3      0.000000  0.000000  0.013978        0.00000
TER    2204      GLY A 282
TER    4408      GLY B 282
MASTER      339    0    4   22   16    0    0    6 4738    2   80   48
END